publication date: Dec. 1, 2010
In this issue:
NCI Proposal Would Give Drug Sponsors Commercial Rights To Biomarker Inventions.
Seattle Institutions Win $16 Million In Grants For Comparative Effectiveness Research.
Paul Okunieff Named Director At UF Shands Cancer Center.
Download (PDF 492K)
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.